The USFDA has approved an abdominal stent-graft system for the repair of an abdominal aortic aneurysm below the renal artery. The abdominal stent-graft system consists of a tube-shaped implant made up of nitinol, polyester, and platinum-iridium, along with a delivery catheter. The device is required to be inserted into the femoral artery through a small incision and guided to an aneurysm site to facilitate a new path for blood flow. The improved blood flow will then reduce the pressure on the weakened and bulging sections of the aorta.
This device stops further growth and rupture of the aneurysm and prevents the associated risk of death. A clinical study evaluated the efficacy and safety of the device for 150 patients. After the procedure, around 93% of the patients were successfully treated and did not experience aneurysm-related complications for up to one year. However, the USFDA has…
